Restoring normoglycaemia by use of a very low calorie diet in long‐ and short‐duration Type 2 diabetes
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Aims: To establish whether an 8‐week very‐low‐calorie diet could improve glycaemic control in Type 2 diabetes of long duration. Methods: A total of 29 people with Type 2 diabetes [short‐duration group (diabetes duration < 4 years), n = 15; long‐duration group (diabetes duration > 8 years), n = 14] completed an 8‐week very‐low‐calorie diet, with assessments of fasting anthropometry, blood tests and blood pressure at baseline and weeks 1, 4 and 8 of the diet. Results: Similar weight loss was achieved in the short‐ and long‐duration groups (14.8 ± 0.8% and 14.4 ± 0.7% respectively; P = 0.662). The glucose response to acute calorie restriction was heterogeneous in the long‐duration group with some responding similarly to those in the short‐duration group, some responding, but only slowly, and others not responding at all. Overall, HbA 1c concentration in the short‐ vs. long‐duration groups fell to 44 ± 2 vs. 64 ± 6 mmol/l (6.2 ± 0.2 vs. 8.0 ± 0.5%; P = 0.002). Fasting plasma glucose levels decreased to 5.8 ± 0.2 vs. 8.4 ± 1.1 mmol/l (P = 0.024) respectively. A total of 87% of the short‐duration group and 50% of the long‐duration group achieved non‐diabetic fasting plasma glucose levels at week 8. Clinically significant improvements in blood pressure and lipid profile were seen regardless of diabetes duration. Conclusion: In people with Type 2 diabetes of > 8 years' duration, a therapeutic trial of a very‐low‐calorie diet may be undertaken with a 50% chance of achieving non‐diabetic fasting glucose levels off all antidiabetic therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
U.K. Prospective Diabetes Study Group (1995) · Diabetes · doi:10.2337/diab.44.11.1249 · Cited by 1,923
Lim, E. L., Hollingsworth, K. G., Aribisala, B. S., Chen, M. J., Mathers, J. C., & Taylor, R. (2011) · Diabetologia · doi:10.1007/s00125-011-2204-7 · Cited by 1,164
Self-citationTabák, A. G., Jokela, M., Akbaraly, T. N., Brunner, E. J., Kivimäki, M., & Witte, D. R. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60619-x · Cited by 898
The Treatment of Hypertension in Adult Patients With Diabetes
Arauz-Pacheco, C., Parrott, M. A., & Raskin, P. (2002) · Diabetes Care · doi:10.2337/diacare.25.1.134 · Cited by 326
Gastric bypass and banding equally improve insulin sensitivity and β cell function
Bradley, D., Conte, C., Mittendorfer, B., Eagon, J. C., Varela, J. E., Fabbrini, E., Gastaldelli, A., Chambers, K. T., Su, X., Okunade, A., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci64895 · Cited by 244
Sattar, N., McConnachie, A., Ford, I., Gaw, A., Cleland, S. J., Forouhi, N. G., McFarlane, P., Shepherd, J., Cobbe, S., & Packard, C. (2007) · Diabetes · doi:10.2337/db06-1256 · Cited by 127
Rapid improvement in diabetes after gastric bypass surgery
Lingvay, I., Guth, E., Islam, A., & Livingston, E. (2013) · Diabetes Care · doi:10.2337/dc12-2316 · Cited by 116
Cited by
Chatterjee, S., Khunti, K., & Davies, M. J. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30058-2 · Cited by 2,577
Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms
Petrie, J. R., Guzik, T. J., & Touyz, R. M. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.12.005 · Cited by 1,787
“calorie liquid replacement diet.(93) In obese patients, this can also occur after successful bariatric surgery, particularly the Roux-en-Y procedure.”
BackgroundInsulin resistance and sarcopenia: mechanistic links between common co-morbidities
Cleasby, M. E., Jamieson, P. M., & Atherton, P. J. (2016) · Journal of Endocrinology · doi:10.1530/joe-15-0533 · Cited by 596
Diet and exercise in the prevention and treatment of type 2 diabetes mellitus
Magkos, F., Hjorth, M. F., & Astrup, A. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0381-5 · Cited by 469
Steven, S., Hollingsworth, K. G., Al-Mrabeh, A., Avery, L., Aribisala, B., Caslake, M., & Taylor, R. (2016) · Diabetes Care · doi:10.2337/dc15-1942 · Cited by 418
Type 2 Diabetes: The Pathologic Basis of Reversible β-Cell Dysfunction
White, M. G., Shaw, J. A. M., & Taylor, R. (2016) · Diabetes Care · doi:10.2337/dc16-0619 · Cited by 174
Self-citationThe Diabetes Remission Clinical Trial (DiRECT): protocol for a cluster randomised trial
Leslie, W. S., Ford, I., Sattar, N., Hollingsworth, K. G., Adamson, A., Sniehotta, F. F., McCombie, L., Brosnahan, N., Ross, H., Mathers, J. C., et al. (2016) · BMC Family Practice · doi:10.1186/s12875-016-0406-2 · Cited by 132
“The subsequent Counterbalance study [23] found that this dramatic reversal of T2DM occurs most reliably in patients with diabetes duration under 6 years since diagnosis.”
BackgroundSelf-citationLi, C., Sadraie, B., Steckhan, N., Kessler, C., Stange, R., Jeitler, M., & Michalsen, A. (2017) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0043-101700 · Cited by 113
Fasting and rapamycin: diabetes versus benevolent glucose intolerance
Blagosklonny, M. V. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1822-8 · Cited by 74
Rosenfeld, R. M., Kelly, J. H., Agarwal, M., Aspry, K., Barnett, T., Davis, B. C., Fields, D., Gaillard, T., Gulati, M., Guthrie, G. E., et al. (2022) · American Journal of Lifestyle Medicine · doi:10.1177/15598276221087624 · Cited by 71
Rehackova, L., Araújo‐Soares, V., Adamson, A. J., Steven, S., Taylor, R., & Sniehotta, F. F. (2017) · Diabetic Medicine · doi:10.1111/dme.13426 · Cited by 69
Self-citationLow carbohydrate dietary approaches for people with type 2 diabetes-a narrative review
Wheatley, S. D., Deakin, T. A., Arjomandkhah, N. C., Hollinrake, P. B., & Reeves, T. E. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.687658 · Cited by 50
Participant experiences in the Diabetes REmission Clinical Trial (DiRECT)
Rehackova, L., Rodrigues, A. M., Thom, G., Brosnahan, N., Barnes, A. C., McCombie, L., Leslie, W. S., Zhyzhneuskaya, S., Peters, C., Adamson, A. J., et al. (2022) · Diabetic Medicine · doi:10.1111/dme.14689 · Cited by 46
Self-citationRemission of Type 2 Diabetes with Very Low-Calorie Diets—A Narrative Review
Juray, S., Axen, K. V., & Trasino, S. E. (2021) · Nutrients · doi:10.3390/nu13062086 · Cited by 45
“This small study found, similar to the Counterpoint and Counterbalance studies [17,20,21], that improvement in glycemic control was apparent in the first 7 days of onset of the VLCD and that duration of T2D was a predictor of remission (mean duration of 2 years vs.”
BackgroundResultUmphonsathien, M., Prutanopajai, P., Aiam‐O‐Ran, J., Thararoop, T., Karin, A., Kanjanapha, C., Jiamjarasrangsi, W., & Khovidhunkit, W. (2019) · Food Science & Nutrition · doi:10.1002/fsn3.956 · Cited by 44
“Collectively, these studies suggest that the underlying pathophysiologic defects of type 2 DM can be reversed by VLCD (Lim et al., 2011; Malandrucco et al., 2012; Steven & Taylor, 2015; Steven et al., 2016).”
BackgroundBrown, A., & Leeds, A. R. (2019) · Nutrition Bulletin · doi:10.1111/nbu.12372 · Cited by 43
Kloecker, D. E., Zaccardi, F., Baldry, E., Davies, M. J., Khunti, K., & Webb, D. R. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13727 · Cited by 25
Obesity in older adults: Effect of degree of weight loss on cardiovascular markers and medications
Haywood, C. J., Prendergast, L. A., Lim, R., Lappas, M., Lim, W. K., & Proietto, J. (2019) · Clinical Obesity · doi:10.1111/cob.12316 · Cited by 19
Dambha-Miller, H., Hounkpatin, H. O., Stuart, B., Farmer, A., & Griffin, S. (2023) · PLOS ONE · doi:10.1371/journal.pone.0290791 · Cited by 13
Dambha-Miller, H., Day, A., Kinmonth, A. L., & Griffin, S. J. (2021) · Family Practice · doi:10.1093/fampra/cmaa086 · Cited by 12
Metadata
- Authors
- Steven, S., & Taylor, R.
- Venue
- Diabetic Medicine
- Publisher
- Wiley
- Published
- 2015-02-26
- Volume
- 32
- Issue
- 9
- Pages
- 1149-1155
- ISSN
- 0742-3071 (ISSN-L)
- 1464-5491
- OpenAlex
- W2144354169
- Cited by
- 122
- References
- 8
- FWCI
- 11.39
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.